Emerging MS therapies – Part II


REPORT FROM THE WORLD CONGRESS ON TREATMENT AND RESEARCH IN MS – A number of new therapies are currently in development for the treatment of MS. In part two of this two-part article, we summarize the most recent data presented at the World Congress. (See Emerging MS therapies – Part I for information on cladribine, teriflunomide and fingolimod.)

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page